See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Jan. 2, 2007

Pancreatic Cancer Healthy Patient Studies Diabetes - Type 2

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Pancreatic Cancer

This study will evaluate the safety and effectiveness of TNFerade Biologic when administered with 5-FU and radiation therapy as first-line treatment of unresectable locally advanced pancreatic cancer. You may be eligible to participate if you are age 18 or older with unresectable, locally advanced adenocarcinoma of the pancreas. Additional criteria may apply.

The research site is in Denver, Colo.

More information

Please see http://www.centerwatch.com/patient/studies/cat35.html.

-----

Healthy Patient Studies

Covance GFI Research is looking for healthy men and women to participate in a medical research study. To qualify you must be age 18-55, a non-smoker, and willing to stay at the research center for seven consecutive overnights and make one outpatient visit.

The research site is in Evansville, Ind.

More information

Please see http://www.centerwatch.com/patient/studies/phasei.html.

-----

Diabetes - Type 2

You may qualify for this study of an investigational medication to treat type 2 diabetes if you are ages 18 to 80, have been diagnosed with type 2 diabetes, and are currently on a stable dose of metformin or sulfonylurea monotherapy.

The research site is in Mount Pleasant, SC.

More information

Please see http://www.centerwatch.com/patient/studies/cat603.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.